| 1 |
19129086 | Influence of SLCO1B1 and CYP2C8 gene polymorphisms on rosiglitazone pharmacokinetics in healthy volunteers. | 2008 Sep |
1 |
| 2 |
16447051 | Pioglitazone, an in vitro inhibitor of CYP2C8 and CYP3A4, does not increase the plasma concentrations of the CYP2C8 and CYP3A4 substrate repaglinide. | 2006 Mar |
1 |
| 3 |
16670899 | Montelukast and zafirlukast do not affect the pharmacokinetics of the CYP2C8 substrate pioglitazone. | 2006 Jul |
1 |
| 4 |
17214065 | The pharmacokinetics of pioglitazone in Thai healthy subjects. | 2006 Dec |
1 |
| 5 |
15606443 | The effect of trimethoprim on CYP2C8 mediated rosiglitazone metabolism in human liver microsomes and healthy subjects. | 2005 Jan |
1 |
| 6 |
15900286 | Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone. | 2005 May |
1 |
| 7 |
15371985 | Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazone. | 2004 Sep |
1 |
| 8 |
15373932 | Effect of ketoconazole on the pharmacokinetics of rosiglitazone in healthy subjects. | 2004 Oct |
1 |